ACUR — Acura Pharmaceuticals Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.03m
- $0.16m
- $1.56m
Brief: Acura Pharmaceuticals to develop abuse deterrent hydrocodone with Limitx technology
Brief: Acura Pharma says aware that Purdue Pharma commenced lawsuit against co
Brief: Acura Pharma reports topline results from Nexafed extended clinical study
Reuters Insider - Intel Adjusts its Expectations, and More
Reuters Insider - Intel Adjusts its Expectations, and More
Brief: Acura Pharmaceuticals Q4 loss per share $0.06
Reuters Insider - Thu., Feb. 26: Watch Kohl's Stock on Upbeat Earnings
Reuters Insider - Thu., Feb. 26: Watch Kohl's Stock on Upbeat Earnings
Brief: Acura Pharmaceuticals initiates clinical study of meth-resistant Nexafed extended-release formulations
Brief: Acura Pharmaceuticals expands meth-resistant decongestant line with Nexafed
Reuters Insider - Madonna: hack was "deeply devastating and hurtful experience"
Brief: Acura, Egalet to commercialize immediate release oxycodone product
Brief: Acura Pharmaceuticals acknowledges distribution of Nexafed by Kmart Pharmacy
Brief: Acura Pharmaceuticals files citizen petition with FDA
Brief: Acura Pharmaceuticals receives additional U.S. patent for abuse deterrent drug formulations
Brief: Acura Pharmaceuticals reports Q3 loss per share $0.06
Market Pulse: Daktronics, DSW, gold stocks, Vivus, Wet Seal
Reuters Insider - Honda unveils 2015 Fit at 2014 Auto Show
Market Pulse: Onyx Pharmaceuticals, Acura, Interdigital, Apple